HomeBVS • NASDAQ
add
Bioventus Inc
Previous close
$6.93
Day range
$6.96 - $7.35
Year range
$5.81 - $14.37
Market cap
572.97M USD
Avg Volume
476.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 147.66M | -2.35% |
Operating expense | 83.71M | -7.44% |
Net income | 7.46M | 129.04% |
Net profit margin | 5.05 | 129.74% |
Earnings per share | 0.21 | 10.53% |
EBITDA | 30.43M | 15.76% |
Effective tax rate | 10.09% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 32.91M | 2.86% |
Total assets | 706.79M | -10.78% |
Total liabilities | 505.49M | -16.19% |
Total equity | 201.30M | — |
Shares outstanding | 66.89M | — |
Price to book | 2.88 | — |
Return on assets | 6.57% | — |
Return on capital | 8.25% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 7.46M | 129.04% |
Cash from operations | 25.94M | 71.07% |
Cash from investing | -1.37M | -1,677.92% |
Cash from financing | -14.66M | -86.91% |
Net change in cash | 10.11M | 48.19% |
Free cash flow | 10.94M | -73.33% |
About
Founded
2011
Website
Employees
950